Talk:Bioblast 2022: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 73: | Line 73: | ||
|- | |- | ||
| || || 16:15 || [[Granata 2022 Abstract Bioblast |Exercise training-induced enhancement of electron flow to the OXPHOS system is more important than increasing the OXPHOS machinery content to improve ATP generation in human skeletal muscle]] || [[Granata Cesare]] | | || || 16:15 || [[Granata 2022 Abstract Bioblast |Exercise training-induced enhancement of electron flow to the OXPHOS system is more important than increasing the OXPHOS machinery content to improve ATP generation in human skeletal muscle]] || [[Granata Cesare]] | ||
|- | |- | ||
|- | |- | ||
| || || 16:20 || [[Chabi 2022 Abstract Bioblast|Coordination between MAMs, mitochondrial function and protein synthesis in exercised and myopathic muscles]] || [[Chabi Beatrice]] | | || || 16:20 || [[Chabi 2022 Abstract Bioblast|Coordination between MAMs, mitochondrial function and protein synthesis in exercised and myopathic muscles]] || [[Chabi Beatrice]] | ||
|- | |- | ||
|- | |- | ||
Line 132: | Line 130: | ||
|- | |- | ||
|- | |- | ||
| || || 10:25 || [[Mutschler 2022 MitoFit|Membranes as therapeutic targets - liposomes as therapeutic options]] || [Mutschler Rainer]] | | || || 10:25 || [[Mutschler 2022 MitoFit|Membranes as therapeutic targets - liposomes as therapeutic options]] || [[Mutschler Rainer]] | ||
|- | |- | ||
|- | |- |
Revision as of 18:21, 2 June 2022
Program
2022-06-29 Day 1 of scientific presentations
Impact of nitric oxide promotors on mitochondrial bioenergetics in a murine model of Alzheimer's Disease || Irving Brian A
2022-06-30 Day 2 of scientific presentations